28
March
2019
|
11:27
Europe/Amsterdam

Novel treatment for liver cancer gets funding boost

A research collaboration between Duke-NUS Medical School, the Singapore General Hospital, and biotechnology firm Lion TCR has developed a novel treatment consisting of cell therapy for patients with Hepatocellular Carcinoma, a form of liver cancer common in Asia. The team is working to improve the treatment while making it more affordable and widely available.